Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (161)

2024

  1. 3D-printed Laponite/Alginate hydrogel-based suppositories for versatile drug loading and release

    Drug Delivery and Translational Research, Vol. 14, Núm. 12, pp. 3385-3403

  2. Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors

    European Journal of Hospital Pharmacy, Vol. 31, Núm. 5, pp. 409-415

  3. Effects of a pharmacist designed clinical decision support system on antimicrobial stewardship

    Applied Clinical Informatics

  4. Enriched mesoporous bioactive glass scaffolds as bone substitutes in critical diaphyseal bone defects in rabbits

    Acta Biomaterialia, Vol. 180, pp. 104-114

  5. Evaluation of soluble P-selectin as a predictive biomarker in acute symptomatic pulmonary embolism: Insights from a prospective observational study

    European Journal of Haematology, Vol. 113, Núm. 2, pp. 201-207

  6. Experience of patients with immune-mediated inflammatory diseases seen in a multidisciplinary integrated care unit

    Journal of Healthcare Quality Research, Vol. 39, Núm. 5, pp. 283-290

  7. In Vivo Detection of Staphylococcus aureus Infections Using Radiolabeled Antibodies Specific for Bacterial Toxins

    International Journal of Biomedical Imaging, Vol. 2024

  8. Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury

    Redox Biology, Vol. 71

  9. Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study

    Farmacia Hospitalaria

  10. Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain

    BMC Geriatrics, Vol. 24, Núm. 1

  11. Progesterone promotes CXCl2-dependent vaginal neutrophil killing by activating cervical resident macrophage–neutrophil crosstalk

    JCI Insight , Vol. 9, Núm. 20

  12. Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient

    Journal of Oncology Pharmacy Practice

  13. Soluble urokinase type plasminogen activator receptor (suPAR) and mortality in acute pulmonary embolism

    Medicina Clinica, Vol. 163, Núm. 6, pp. 281-285

  14. The Potential Role of CA-125 as a Biomarker for Short-Term Mortality Risk in Patients with Acute Symptomatic Pulmonary Embolism

    Journal of Clinical Medicine, Vol. 13, Núm. 12

  15. Treatment with Rasburicase in Hospitalized Patients with Cardiorenal Syndrome: Old Treatment, New Scenario

    International Journal of Molecular Sciences, Vol. 25, Núm. 6

  16. Tubular biomarkers and histology in lupus nephritis

    International Journal of Rheumatic Diseases, Vol. 27, Núm. 6

  17. Tubular biomarkers in proteinuric kidney disease: histology correlation and kidney prognosis of tubular biomarkers

    Clinical Kidney Journal, Vol. 17, Núm. 5

  18. [Translated article] Development and consensus of a dashboard model to evaluate research activity in Spanish Hospital Pharmacy Services

    Farmacia Hospitalaria, Vol. 48, pp. TS28-TS34